Celltrion announced on the 31st that it has signed a joint research and development agreement for a new immuno-oncology drug with MustBio, a domestic ...

DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years ...

The United States Formulation Development Outsourcing Market is set to surge from US$ 10.11 billion in 2024 to US$ 18.11 ...

Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest flexible solutions to help boost efficiency and scale in biopharmaceutical manufacturing at every stage of ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...

Laxxon Medical, a leading pharmaceutical technology company, pioneering a new generation of advanced oral drug delivery systems, today announced that it will be attending BIO-Europe 2025 and the ...

The draft guidance, which is touted as a way to reduce the cost and time-associated burden of biosimilar development, has ...

Nigel Langley of gChem stresses excipient innovation, safer solvents, and supply chain resilience for pharma’s future in part ...

Together, the companies aim to receive 4D-150 marketing approval and commercialization in ... are in clinical or preclinical development and have not yet been approved for marketing by the U.S. Food ...

There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...